ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96 | +118.2% | 88,234 | +193.1% | 0.01% | +66.7% |
| Q4 2022 | $44 | -99.9% | 30,103 | -25.7% | 0.01% | +50.0% |
| Q3 2022 | $44,000 | +51.7% | 40,503 | +133.7% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | -42.0% | 17,328 | -29.2% | 0.00% | -50.0% |
| Q1 2022 | $50,000 | -79.7% | 24,470 | -48.5% | 0.00% | -81.8% |
| Q3 2021 | $246,000 | +23.6% | 47,542 | +139.6% | 0.02% | -4.3% |
| Q2 2020 | $199,000 | -50.7% | 19,845 | -67.2% | 0.02% | +9.5% |
| Q4 2017 | $404,000 | +75.7% | 60,473 | +115.6% | 0.02% | +90.9% |
| Q3 2017 | $230,000 | – | 28,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |